Science Arts, Inc. (TYO:4412)
Japan · Delayed Price · Currency is JPY 1,440.00
+62.00 (4.50%)
Oct 16, 2026, 3:30 PM JST
Science Arts Balance Sheet
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Cash & Equivalents | 1,352 | 1,579 | 562 | 504 | 663 |
Short-Term Investments | 499 | - | - | - | - |
Cash & Short-Term Investments | 1,851 | 1,579 | 562 | 504 | 663 |
Cash Growth | 17.23% | 180.96% | 11.51% | -23.98% | 155.00% |
Receivables | 116 | 151 | 101 | 66 | 35 |
Inventory | 130 | 60 | 65 | 76 | 28 |
Prepaid Expenses | 38 | 43 | 23 | 17 | 11 |
Other Current Assets | 4 | 1 | 1 | 4 | 2 |
Total Current Assets | 2,139 | 1,834 | 752 | 667 | 739 |
Property, Plant & Equipment | 39 | 109 | 108 | 112 | 30 |
Long-Term Investments | 219 | 100 | 92 | 113 | 31 |
Long-Term Deferred Tax Assets | 62 | 33 | - | - | - |
Other Long-Term Assets | - | 1 | 1 | 2 | 1 |
Total Assets | 2,459 | 2,077 | 953 | 894 | 801 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Accounts Payable | 25 | 40 | 8 | 16 | 14 |
Accrued Expenses | 56 | 39 | 30 | 41 | 19 |
Current Portion of Long-Term Debt | 31 | 40 | 48 | - | - |
Current Income Taxes Payable | 101 | 111 | 57 | 65 | 35 |
Current Unearned Revenue | 555 | 370 | 222 | 180 | 135 |
Other Current Liabilities | 7 | 10 | 8 | 13 | 3 |
Total Current Liabilities | 775 | 610 | 373 | 315 | 206 |
Long-Term Debt | 14 | 27 | 40 | - | - |
Long-Term Deferred Tax Liabilities | - | - | 6 | 9 | - |
Other Long-Term Liabilities | 1 | 47 | 58 | 62 | 25 |
Total Liabilities | 790 | 684 | 477 | 386 | 231 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Common Stock | 459 | 450 | 52 | 52 | 50 |
Additional Paid-In Capital | 1,200 | 1,188 | 781 | 781 | 765 |
Retained Earnings | 13 | -241 | -353 | -321 | -240 |
Treasury Stock | -3 | -3 | -3 | -3 | -4 |
Comprehensive Income & Other | - | -1 | -1 | -1 | -1 |
Shareholders' Equity | 1,669 | 1,393 | 476 | 508 | 570 |
Total Liabilities & Equity | 2,459 | 2,077 | 953 | 894 | 801 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Total Debt | 45 | 67 | 88 | - | - |
Net Cash (Debt) | 1,806 | 1,512 | 474 | 504 | 663 |
Net Cash Growth | 19.44% | 218.99% | -5.95% | -23.98% | 155.00% |
Net Cash Per Share | 220.06 | 192.96 | 72.00 | 76.64 | 197.43 |
Filing Date Shares Outstanding | 8.11 | 8.1 | 6.58 | 6.58 | 3.28 |
Total Common Shares Outstanding | 8.11 | 8.1 | 6.58 | 6.58 | 3.28 |
Working Capital | 1,364 | 1,224 | 379 | 352 | 533 |
Book Value Per Share | 205.72 | 171.99 | 72.30 | 77.17 | 173.72 |
Tangible Book Value | 1,669 | 1,393 | 476 | 508 | 570 |
Tangible Book Value Per Share | 205.72 | 171.99 | 72.30 | 77.17 | 173.72 |